Anuh Pharma surged 12.6% to Rs 230.50 at 15:00 IST on BSE after the company announced that French National Agency for Medicines and Health Products Safety granted EUGMP certificate to its manufacturing site.
The announcements were made during market hours today, 16 December 2016.Meanwhile, the BSE Sensex was up 9.07 points, or 0.03%, to 26,528.14.
High volumes were witnessed on the counter. On the BSE, 1.35 lakh shares were traded in the counter so far, compared with an average volume of 14,594 shares in the past one quarter. The stock had hit a high of Rs 245 and a low of Rs 208.35 so far during the day. The stock had hit a 52-week high of Rs 344 on 21 December 2015. The stock had hit a 52-week low of Rs 159 on 21 April 2016.
Anuh Pharma announced that French National Agency for Medicines and Health Products Safety (ANSM) considers manufacturing site of Anuh Pharma at E-17/3 and E-17/4, MIDC Tarapur, Taluka Palghar, District Thane 401506, Boisar, Maharashtra, India site in compliance with principles of good manufacturing practices (GMP) for active substances referred to in Article 47 of directive 2001/83/EC and has granted European Union good manufacturing practices (EUGMP) certificate for Erythromycin Ethyl Succinate and Pyrazinamide products.
ANSM had carried out the inspection of the manufacturing site on 16 September 2016.
Separately, Anuh Pharma announced that World Health Organisation (WHO), Geneva, considers the manufacturing site of the company at E-17/3 and E-17/4, M.I.D.C. Tarapur, Taluka Palghar, District Thane 401506, Boisar, Maharashtra, India in compliance to WHO GMPs for Pyrazinamide APIMF158 and Sulfadoxine APIMF234, active pharmaceutical ingredients.
The inspection of the manufacturing site by the WHO was carried out on 16 September 2016.
Also Read
Anuh Pharma's net profit dropped 34.5% to Rs 4.87 crore on 44.2% drop in net sales to Rs 50.07 crore in Q2 September 2016 over Q2 September 2015.
Anuh Pharma manufactures active pharmaceutical ingredients (API's). The company is one of the largest producers of macrolides in the country.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content